Terebellum, Ireland and UK-based Life Sciences Solutions Provider, Announces Appointments Following Expansion into New Markets

More>>

PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing

Cellaca® PLX Image Cytometer redefines workflows, addresses multiple Critical Quality Attributes

September 26, 2022, WALTHAM, Mass.: PerkinElmer, Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today launched the Cellaca® PLX Image Cytometry System, a first-of-its-kind benchtop platform that enables researchers to assess multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow, including cell identity, quality and quantity. More>>

Novartis Plans to Petition the U.S. Supreme Court to Uphold Validity of the Gilenya® (fingolimod) Dosing Regimen Patent

Basel, 21 September, 2022 — Today, Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) has denied its petition to rehear the negative decision regarding the validity of US Patent No. 9,187,405, covering a dosing regimen for 0.5mg Gilenya. Novartis plans to file a petition seeking further review of the CAFC’s decision with the US Supreme Court. More>>

Quinten Health Closes its Financing Round to Advance Disease Modelling Platforms and Virtual Twins in Real-World

Paris, September 21st, 2022 – Life Science Newswire – QUINTEN HEALTH, a pioneer in real-world data science, Artificial Intelligence (AI) and Machine Learning (ML) for precision care, today announces that it has closed its financing round to advance disease modeling platforms and virtual twins in real-world, as part of the Quinten Group's €14 million growth equity investment from TECHLIFE CAPITAL and MACSF, essentially dedicated to the healthcare activities of the Quinten group. More>>

LifeArc Joins Forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to Strengthen Antimicrobial Discovery Efforts

Pivotal partnership seeks to transform Cystic Fibrosis research

LifeArc, a national medical research charity, is joining the Cystic Fibrosis (CF) Antimicrobial Resistance (AMR) Syndicate in a strategic partnership alongside Cystic Fibrosis Trust and Medicines Discovery Catapult (MDC). More>>

Paradigm Clinical Research Names Industry Veteran Kurt Mussina as CEO as Expansion Plans Are Set in Motion

More>>

ACG appoints Shankar Gupta as Chief Sales Officer

Industry authority to re-join business in a newly created role

ACG, the world’s largest integrated pharmaceutical and nutraceutical manufacturing solutions provider, is delighted to announce that Shankar Gupta will be re-joining the business in the newly created role of chief sales officer. More>>

FlyPharma Conference Europe 2022 Shares the Latest Supply Chain Challenges and Advice for Better Industry Collaboration

On 20-21 September 2022, the FlyPharma Conference Europe made a welcome return as a live, in-person event. The conference was warmly received by its delegates and declared a resounding success, with some familiar faces from previous events and many new ones in attendance across the two days. More>>

Elligo’s Rebecca Kush, Ph.D., Elected Chair of Vulcan Advisory Council: Connecting Clinical Research and Healthcare

More>>

WCG IRB Expands Phase I Review Services, Partners With Dr. Vince Clinical Research

More>>